Biomarkers, interventions and healthy ageing

New Biotechnology

Volumn 30, Issue 4, 2013, Pages 373-377

  Kenessary, Almas ^a   Zhumadilov, Zhaxybay ^a   Nurgozhin, Talgat ^a   Kipling, David ^b   Yeoman, Mark ^c   Cox, Lynne ^d   Ostler, Elizabeth ^c   Faragher, Richard ^c  

^a NAZARBAYEV UNIVERSITY   (Kazakhstan)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF BRIGHTON   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEALTH CARE;

AGEING PROCESS; CROSS-SPECIES; DEVELOPING WORLD; GENETIC PATHWAYS; HUMAN LIVES; POPULATION AGEING; QUALITY OF LIFE; WIDE SPECTRUM;

DEVELOPING COUNTRIES;

ANTIOXIDANT; BIOLOGICAL MARKER; RAPAMYCIN;

AGING; ALZHEIMER DISEASE; ARTICLE; CELL AGING; CONCEPTUAL FRAMEWORK; FERTILITY; HUMAN; LIFESPAN; LONGEVITY; MORBIDITY; MORTALITY; MUTANT; MUTATION; NONHUMAN; PLEIOTROPY; PRIORITY JOURNAL; QUALITY OF LIFE; REPRODUCTION; SENESCENCE; HEALTH; PHYSIOLOGY; PREVENTIVE MEDICINE;

AGING; BIOLOGICAL MARKERS; HEALTH; HUMANS; LONGEVITY; PREVENTIVE MEDICINE;

EID: 84877832564     PISSN: 18716784     EISSN: 18764347     Source Type: Journal    
DOI: 10.1016/j.nbt.2012.11.018     Document Type: Article

References (47)

1. Wilmoth J.R. Demography of longevity: past, present, and future trends. Experimental Gerontology 2000, 35:1111-1129.
2. Lutz W., Sanderson W., Scherbov S. Doubling of world population unlikely. Nature 1997, 387:803-805.
3. Cutler D., Miller G. The role of public health improvements in health advances: the twentieth-century United States. Demography 2005, 42:1-22.
4. Venkitachalam L., Lei Y., Stolker J.M., Mahoney E.M., Amin A.P., Lindsey J.B., et al. Clinical and economic outcomes of liberal versus selective drug-eluting stent use: insights from temporal analysis of the multicenter Evaluation of Drug Eluting Stents and Ischemic Events (EVENT) registry. Circulation 2011, 124:1028-1037.
5. NHS National Statistics. Prescriptions dispensed in the community statistics for 1997 to 2007: England. ISBN: 978-1-84636-223-1; 2008.
6. Summerfield C, Babb P, editors. Social trends 34. Published by London: TSO. ISBN 0 11 621732 4; 2004.
7. Goldman DP, Shang B, Bhattacharya J, Garber AM, Hurd M, Joyce GF et al. Consequences of health trends and medical innovation for the future elderly. Health affairs - web exclusive available at; 2005. http://content.healthaffairs.org/.
8. Comfort A. The biology of senescence 1979, Churchill-Livingstone. third edition.
9. Strehlar B. Time, cells and aging 1977, Academic Press. second edition.
10. Medawar P.B. An unresolved problem in biology 1952, Lewis.
11. Williams G.C. Pleiotropy, natural selection, and the evolution of senescence. Evolution 1957, 11:398-411.
12. Prowse, Partridge The effects of reproduction on longevity and fertility in male Drosophila melanogaster. Journal of Insect Physiology 1997, 43:501-512.
13. Kirkwood T.B.L. Evolution of ageing. Nature 1977, 270:301-304.
14. Escobar J.S., Jarne P., Charmantier A., David P. Outbreeding alleviates senescence in hermaphroditic snails as expected from the mutation-accumulation theory. Current Biology 2008, 18:906-910.
15. Rose M.R. Evolution of late-life mortality in Drosophila melanogaster. Evolution 2002, 56:1982-1991.
16. Speakman J.R., Król E. The heat dissipation limit theory and evolution of life histories in endotherms - time to dispose of the disposable soma theory?. Integrative and Comparative Biology 2010, 50:793-807.
17. Tabatabaie V., Atzmon G., Rajpathak S.N., Freeman R., Barzilai N., Crandall J., et al. Exceptional longevity is associated with decreased reproduction. Aging (Albany, NY) 2011, 3:1202-1205.
18. Reznick D., Bryant M., Holmes D. The evolution of senescence and post-reproductive lifespan in guppies (Poecilia reticulata). PLoS Biology 2006, 4:e7.
19. Godin J.G., McDonough H.E. Predator preference for brightly coloured males in the guppy: a viability cost for a sexually selected trait. Behavioural Ecology 2003, 14:194-200.
20. Yoshida K., Fujisawa T., Hwang J.S., Ikeo K., Gojobori T. Degeneration after sexual differentiation in Hydra and its relevance to the evolution of ageing. Gene 2006, 385:64-70.
21. Martínez D.E., Levinton J.S. Asexual metazoans undergo senescence. Proceedings of the National Academy of Sciences of the United States of America 1992, 89:9920-9923.
22. Ridgway I.D., Richardson C.A., Austad S.N. Maximum shell size, growth rate, and maturation age correlate with longevity in bivalve molluscs. Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2011, 66:183-190.
23. Yeoman M., Scutt G., Faragher R. Insights into CNS ageing from animal models of senescence. Nature Reviews Neuroscience 2012, 13:435-445.
24. Doll R. There is no such thing as ageing. British Medical Journal 1997, 315:1030-1032.
25. Klass M.R. A method for the isolation of longevity mutants in the nematode Caenorhabditis elegans and initial results. Mechanisms of Ageing and Development 1983, 22:279-286.
26. Kenyon C., Chang J., Gensch E., Rudner A., Tabtiang R. A C. elegans mutant that lives twice as long as wild type. Nature 1993, 366:461-464.
27. Friedman D.B., Johnson T.E. A mutation in the age-1 gene in Caenorhabditis elegans lengthens life and reduces hermaphrodite fertility. Genetics 1988, 118:75-86.
28. Selman C., Lingard S., Choudhury A.I., Batterham R.L., Claret M., Clements M., et al. Evidence for lifespan extension and delayed age-related biomarkers in insulin receptor substrate 1 null mice. FASEB Journal 2008, 22:807-818.
29. Gerstbrein B., Stamatas G., Kollias N., Driscoll M. In vivo spectrofluorimetry reveals endogenous biomarkers that report healthspan and dietary restriction in Caenorhabditis elegans. Aging Cell 2005, 4:127-137.
30. Lewis K.N., Andziak B., Yang T., Buffenstein R. The naked mole-rat response to oxidative stress: just deal with it. Antioxidants and Redox Signalling 2012, [Epub ahead of print].
31. Pérez V.I., Bokov A., Van Remmen H., Mele J., Ran Q., Ikeno Y., et al. Is the oxidative stress theory of aging dead?. Biochimica et Biophysica Acta 2009, 1790:1005-1014.
32. Gems D., Doonan R. Antioxidant defense and aging in C. elegans: is the oxidative damage theory of aging wrong?. Cell Cycle 2009, 8:1681-1687.
33. McElwee J.J., Schuster E., Blanc E., Piper M.D., Thomas J.H., Patel D.S., et al. Evolutionary conservation of regulated longevity assurance mechanisms. Genome Biology 2007, 8:R132.
34. Gems D., McElwee J.J. Broad spectrum detoxification: the major longevity assurance process regulated by insulin/IGF-1 signaling?. Mechanisms of Ageing and Development 2005, 126:381-387.
35. Wilkinson J.E., Burmeister L., Brooks S.V., Chan C.C., Friedline S., Harrison D.E., et al. Rapamycin slows aging in mice. Aging Cell 2012, 11:675-682.
36. Wang S.Y., Yu Q.J., Zhang R.D., Liu B. Core signaling pathways of survival/death in autophagy-related cancer networks. International Journal of Biochemistry and Cell Biology 2011, 43:1263-1266.
37. de Magalhães J.P., Faragher R.G. Cell divisions and mammalian aging: integrative biology insights from genes that regulate longevity. Bioessays 2008, 30:567-578.
38. Itahana K., Campisi J., Dimri G.P. Mechanisms of cellular senescence in human and mouse cells. Biogerontology 2004, 5:1-10.
39. Campisi J. Cellular senescence: putting the paradoxes in perspective. Current Opinion in Genetics and Development 2011, 21:107-112.
40. Coppé J.P., Desprez P.Y., Krtolica A., Campisi J. The senescence-associated secretory phenotype: the dark side of tumor suppression. Annual Review of Pathology 2010, 5:99-118.
41. Burton D.G., Giles P.J., Sheerin A.N., Smith S.K., Lawton J.J., Ostler E.L., et al. Microarray analysis of senescent vascular smooth muscle cells: a link to atherosclerosis and vascular calcification. Experimental Gerontology 2009, 44:659-665.
42. Baker D.J. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 2011, 479:232-236.
43. Ungvari Z., Sosnowska D., Mason J.B., Gruber H., Lee S.W., Schwartz T.S., et al. Resistance to genotoxic stresses in arctica islandica, the longest living noncolonial animal: is extreme longevity associated with a multistress resistance phenotype?. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 2012, [Epub ahead of print].
44. Ravikumar B., Vacher C., Berger Z., Davies J.E., Luo S., Oroz L.G., et al. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nature Genetics 2004, 36:585-595.
45. Spilman P. Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's disease. PLoS One 2010, 5:e9979.
46. Pierce A., Podlutskaya N., Halloran J.J., Hussong S.A., Lin P.Y., Burbank R., et al. Overexpression of heat shock factor 1 phenocopies the effect of chronic inhibition of TOR by rapamycin and is sufficient to ameliorate Alzheimer's-like deficits in mice modeling the disease. Journal of Neurochemistry 2012, [Epub ahead of print].
47. Gafford G.M., Parsons R.G., Helmstetter F.J. Consolidation and reconsolidation of contextual fear memory requires mammalian target of rapamycin-dependent translation in the dorsal hippocampus. Neuroscience 2011, 182:98-104.